CrossrefInfokarte
The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin
Journal of Endocrinology and Metabolism · 2025
DOI: 10.14740/jem1055 ↗Abstract
Kein Abstract verfügbar.
EUVIMED